Q1 FY27 saw record revenue growth of 19.1% year-over-year, with strong gains in patient and sample volumes and improved margins. Strategic investments in R&D, digital infrastructure, and rural outreach supported profitability and future growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.